Large-Scale Antibody Profiling Links Herpesvirus Reactivities to Autoantigens and Chronic Diseases
Herpesvirus infections link directly to human autoantigen targets and subsequent chronic diseases through distinct, virus-specific immune networks, according to a study published in Nature Immunology.
- Researchers profiled immunoglobulin G reactivities against over 4,600 herpesvirus peptides and 15,000 human proteins in two clinical biobank cohorts.
- The investigation identified thousands of viral-autoantigen associations spanning all nine human Herpesviridae species.
- Cytomegalovirus formed the largest multimorbid network, while Epstein-Barr virus converged on pleiotropic autoimmune hubs.
The investigation systematically mapped plasma antibody profiles to understand how persistent viral exposures interact with host proteins at a proteome-wide scale. Bioengineer.org reported that researchers utilized a high-throughput serological technology called molecular indexing of proteins by self-assembly, or MIPSA, to analyze patient samples.
Mass General Brigham Biobank Cohorts
The study evaluated two distinct populations from the Mass General Brigham Biobank with longitudinal electronic health record follow-up spanning from March 1988 through March 2025. The discovery population, designated as the longitudinal lung function cohort, comprised 1,289 asthmatic adults with a median age of 60.3 years, of whom 70.4 percent were female.
The independent validation population, known as the longitudinal electronic health record cohort, contained 763 individuals with a median age of 57.1 years and 53.2 percent female representation. Investigators incubated plasma volumes from these participants with specialized antigen displays, specifically the VirSIGHT platform presenting viral peptide tiles and the HuSIGHT platform presenting human protein autoantigens.

Multiplexed Serological Profiling Results
In the discovery group, detectable antibody reactivities with a prevalence exceeding one percent appeared for 2,323 out of 4,657 viral peptides, accounting for 49.9 percent of the viral library, alongside 2,258 human proteins, according to nature.com. Within the replication group, antibody reactivities surpassing that same threshold emerged for 2,342 viral peptides and 1,064 human proteins.
The research team identified and replicated 3,943 false discovery rate-significant associations across 93 autoantigens. These results revealed previously uncharacterized viral-autoantigen axes, including PHLDA1 and ZNF550, with certain autoantigens predicted by viral peptide reactivities with greater than 85 percent accuracy in independent validation.
Virus-Specific Network Architectures
Integrating immune reactivities with incident disease outcomes demonstrated that herpesvirus-related signatures organize into distinct, virus-specific networks rather than generalized immune chaos. Cytomegalovirus showed the largest number of significant viral-autoantigen pairs with 11,341 associations involving 667 viral peptides and 475 autoantigens in the discovery cohort.
Epstein-Barr virus, herpes simplex virus type 1, and herpes simplex virus type 2 also displayed broad reactivity. Conversely, varicella zoster virus, human herpesvirus 6A, human herpesvirus 6B, human herpesvirus 7, and human herpesvirus 8 contributed fewer associations.
| Cohort Name | Sample Size (n) | Median Age (Years) | Female Percentage |
|---|---|---|---|
| MGBB Longitudinal Lung Function Cohort | 1,289 | 60.3 | 70.4% |
| MGBB Longitudinal EHR Cohort | 763 | 57.1 | 53.2% |
Candidate Viral-Host Immune Axes
The majority of replicated autoantigens proved virus-specific, with 85.8 percent associating with only a single herpesvirus species. Shared autoantigen hubs occurred most frequently between herpes simplex virus type 1 and herpes simplex virus type 2, reflecting their close evolutionary relationship and antigenic similarity.
Future investigations will determine whether these specific viral-autoantigen axes can be targeted clinically to alter disease progression before the onset of overt chronic symptoms.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.